Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Synopsys, Inc. - Common Stock (NQ:SNPS)

613.35 +21.89 (+3.70%)
Streaming Delayed Price Updated: 3:21 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Synopsys, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
Nvidia Is Banking On Chatbots, AI To Speed Up Chip Design Amid Growing Demand: Report
While AI-based tools have their limitations, they are proving to be invaluable for training new chip designers, writing hardware languages, and reporting bugs. 
Via Benzinga
Topics Artificial Intelligence
Market Whales and Their Recent Bets on SNPS Options
Via Benzinga
Amazon Partner MongoDB Breaks Out, Leads Three AI Stocks Near Buy Points
The database software firm broke out Friday, one of five stocks to watch. 
Via Investor's Business Daily
Topics Artificial Intelligence
Unpacking the Latest Options Trading Trends in Synopsys
Via Benzinga
Looking Into Synopsys's Recent Short Interest
Via Benzinga
With the Synopsys Mega-Merger on the Horizon, Does This Top Chip Design Company Stand a Chance?
Keysight Technologies is facing some stiff competition, and one of its peers was recently acquired. 
Via The Motley Fool
Is NASDAQ:SNPS suited for quality investing?
Why SYNOPSYS INC (NASDAQ:SNPS) Deserves Consideration as a Quality Investment. 
Via Chartmill
$1000 Invested In This Stock 15 Years Ago Would Be Worth $27,000 Today
Via Benzinga
Synopsys Unusual Options Activity For January 09
Via Benzinga
Expedia, AI Play Lead Five Stocks Near Buy Points
Strong GDP data gave consumer stocks a boost. 
Via Investor's Business Daily
Topics Artificial Intelligence
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
From Brodsky & Smith LLC
Via GlobeNewswire
These 5 growth stocks are now in buy ranges
Affirm, MongoDB, UIPath, Synopsys and Crispr's charts signal buy opportunities as these top-performing tech and biotech stocks consolidate below prior highs. 
Via MarketBeat
Topics ETFs
4 Stocks to Buy for the Coming AI Wars
You don't want to be caught on the wrong side of the AI war. Here are four stocks to buy to protect yourself... and profit. 
Via InvestorPlace
Topics Artificial Intelligence
S&P 500, Dow Extend All-Time Highs: 'It's A Lot Of Fun For Stock Investors While It Lasts,' Wall Street Veteran Says
Stock market continues upward trend, with all major indexes reaching record highs. Wall Street veteran Ed Yardeni outlines three possible scenarios. 
Via Benzinga
Topics Stocks
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Karuna Therapeutics, Inc. (Nasdaq – KRTX), Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
From Brodsky & Smith LLC
Via GlobeNewswire
2 Software Stocks Are Merging to Bet On AI -- but Investors, Beware of the Hype
Synopsys just made its $35 billion offer for Ansys in a bid to bring AI everywhere. 
Via The Motley Fool
Topics Artificial Intelligence
Stock Market Rally Mixed As Yields Rise; Taiwan Semiconductor, Tesla In Focus: Weekly Review
The major indexes were mixed this week. Taiwan Semi fueled chip gains. 
Via Investor's Business Daily
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
The "buy everything" sentiment that powered equity indices higher last quarter is over. It's a stock picker's market, Marc Chaikin says. 
Via Benzinga
Chipmakers Lead, Markets Slip Overall
Market indices were lower again today, although we continue to see relative strength in A.I.-oriented chipmakers like AMD)and NVIDIA, which were up +8.3% and +3%, respectively 
Via Talk Markets
Synopsys Purchase Of Ansys Creates Silicon-To-Systems Design Leader
Chip design software maker Synopsys emerged as the winning bidder for Ansys on Tuesday. SNPS stock rose on the news. 
Via Investor's Business Daily
US Stocks Drift Lower As Dollar, Treasury Yields Rise, AMD Defies Gravity: What's Driving Markets Tuesday?
The U.S. stock market resumed its decline on Tuesday following a one-day closure for Martin Luther King Jr. Day. The major indices were all in the red around midday trading in New York as investors... 
Via Benzinga
Why Is ANSYS Stock Trading Lower Tuesday?
Synopsys, Inc (SNPS) will acquire ANSYS, Inc (ANSS) for $35B, creating a leader in design solutions. ANSS shareholders will own 16.5% of the combined company. 
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carrols Restaurant Group, Inc. (Nasdaq - TAST), Ansys, Inc. (Nasdaq - ANSS), HomeStreet, Inc. (Nasdaq - HMST)
From Brodsky & Smith LLC
Via GlobeNewswire
Stellantis Layoffs 2024: What to Know About the Latest STLA Job Cuts
Stellantis job cuts are coming for more than 500 workers in the U.S. as the company seeks to reduce its temporary workforce. 
Via InvestorPlace
Topics Workforce
VOD Stock Alert: Vodafone Signs $1.5 Billion AI Deal With Microsoft
Vodafone stock is on the move Tuesday as investors in VOD shares react to the company signing a $1.5 billion deal with Microsoft! 
Via InvestorPlace
Topics Artificial Intelligence
Information Technology Company Synopsys Announces Acquisition of Ansys
Via Benzinga
SNPS Stock Alert: The $35 Billion Reason Synopsys Stock Is Up Today
Synopsys stock is up on Tuesday as it plans to use a mix of cash and shares of SNPS to acquire Ansys in a $35 billion deal. 
Via InvestorPlace
10 Top Strong Buy Stocks That Can Soar 20% or More From Here
What are the "strong buy" stocks analysts are bullish on for 2024? Here are 10 companies that investors should be watching. 
Via InvestorPlace
AstraZeneca: Rebound in 2024 with double-digit earnings growth
AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition 
Via MarketBeat
10 Top Stocks With a Strong Buy Rating Right Now
Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch. 
Via InvestorPlace
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.